<VariationArchive VariationID="983512" VariationName="NM_207361.6(FREM2):c.5162dup (p.Phe1722fs)" VariationType="Duplication" Accession="VCV000983512" Version="5" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="4" DateLastUpdated="2024-02-28" DateCreated="2020-11-06" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="971582" VariationID="983512">
      <GeneList>
        <Gene Symbol="FREM2" FullName="FRAS1 related extracellular matrix 2" GeneID="341640" HGNC_ID="HGNC:25396" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="38687077" stop="38887131" display_start="38687077" display_stop="38887131" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="39261172" stop="39461267" display_start="39261172" display_stop="39461267" Strand="+" />
          </Location>
          <OMIM>608945</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_207361.6(FREM2):c.5162dup (p.Phe1722fs)</Name>
      <CanonicalSPDI>NC_000013.11:38692505:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>13q13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="38692505" stop="38692506" display_start="38692505" display_stop="38692506" variantLength="1" positionVCF="38692505" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="39266642" stop="39266643" display_start="39266642" display_stop="39266643" variantLength="1" positionVCF="39266642" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>F1722fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.39266643dup" Assembly="GRCh37">
            <Expression>NC_000013.10:g.39266643dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.38692506dup" Assembly="GRCh38">
            <Expression>NC_000013.11:g.38692506dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008125.2" sequenceAccession="NG_008125" sequenceVersion="2" change="g.10471dup">
            <Expression>NG_008125.2:g.10471dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207361.6" sequenceAccession="NM_207361" sequenceVersion="6" change="c.5162dup" MANESelect="true">
            <Expression>NM_207361.6:c.5162dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997244.4" sequenceAccession="NP_997244" sequenceVersion="4" change="p.Phe1722fs">
            <Expression>NP_997244.4:p.Phe1722fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="769926034" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00004" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00004" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_207361.6(FREM2):c.5162dup (p.Phe1722fs) AND Fraser syndrome 2" Accession="RCV001263472" Version="3">
        <ClassifiedConditionList TraitSetID="37295">
          <ClassifiedCondition DB="MedGen" ID="C4540036">Fraser syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2020-10-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_207361.6(FREM2):c.5162dup (p.Phe1722fs) AND multiple conditions" Accession="RCV002486009" Version="1">
        <ClassifiedConditionList TraitSetID="52108">
          <ClassifiedCondition DB="MedGen" ID="C4540036">Fraser syndrome 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1852453">Isolated cryptophthalmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-14" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_207361.6(FREM2):c.5162dup (p.Phe1722fs) AND not provided" Accession="RCV003698855" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-27" NumberOfSubmissions="5" NumberOfSubmitters="4" DateCreated="2020-11-06" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18203166</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26552811</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="37295" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38103" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fraser syndrome 2</ElementValue>
                <XRef ID="MONDO:0054738" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FRASRS2</ElementValue>
                <XRef Type="MIM" ID="617666" DB="OMIM" />
              </Symbol>
              <XRef ID="C4540036" DB="MedGen" />
              <XRef ID="MONDO:0054738" DB="MONDO" />
              <XRef Type="MIM" ID="617666" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="52108" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38103" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fraser syndrome 2</ElementValue>
                <XRef ID="MONDO:0054738" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FRASRS2</ElementValue>
                <XRef Type="MIM" ID="617666" DB="OMIM" />
              </Symbol>
              <XRef ID="C4540036" DB="MedGen" />
              <XRef ID="MONDO:0054738" DB="MONDO" />
              <XRef Type="MIM" ID="617666" DB="OMIM" />
            </Trait>
            <Trait ID="4879" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Isolated cryptophthalmia</ElementValue>
                <XRef ID="MONDO:0007410" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cryptophthalmos, unilateral or bilateral, isolated</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ANKYLOBLEPHARON, SIMPLE</ElementValue>
                <XRef Type="MIM" ID="123570" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16797" />
                <XRef ID="16797" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cryptophthalmos is a condition of eyelid malformation with an underlying malformed eye. Complete, incomplete, and symblepharon varieties exist. The skin in complete cryptophthalmos extends uninterrupted from the forehead to the cheek. In the incomplete form, there is medial eyelid fusion, but coincident intact lateral structures. The symblepharon variety presents with fusion of the upper eyelid skin to the superior aspect of the globe. The complete variety is the most common form (summary by Egier et al., 2005).</Attribute>
                <XRef Type="MIM" ID="123570" DB="OMIM" />
              </AttributeSet>
              <XRef ID="91396" DB="Orphanet" />
              <XRef ID="C1852453" DB="MedGen" />
              <XRef ID="MONDO:0007410" DB="MONDO" />
              <XRef Type="MIM" ID="123570" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5036921" SubmissionDate="2022-09-22" DateLastUpdated="2022-10-01" DateCreated="2022-10-01">
        <ClinVarSubmissionID localKey="UCSF114018.2|OMIM:617666" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002576352" DateUpdated="2022-10-01" DateCreated="2022-10-01" Type="SCV" Version="1" SubmitterName="Genomic Medicine Lab, University of California San Francisco" OrgID="506696" OrganizationCategory="laboratory" OrgAbbreviation="UCSF GML" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FREM2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_207361.4:c.5162dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617666" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER</StudyName>
        <StudyDescription>CSER P3EGS Study</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB12091458</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2845700" SubmissionDate="2020-11-03" DateLastUpdated="2020-11-06" DateCreated="2020-11-06">
        <ClinVarSubmissionID localKey="NM_207361.5:c.5162dupA|OMIM:617666" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001441550" DateUpdated="2020-11-06" DateCreated="2020-11-06" Type="SCV" Version="1" SubmitterName="Johns Hopkins Genomics, Johns Hopkins University" OrgID="506823" OrganizationCategory="laboratory" OrgAbbreviation="JHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FREM2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_207361.5:c.5162dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617666" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8462177</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5429330" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_207361.6:c.5162dup|OMIM:123570;617666" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002776409" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_207361.6:c.5162dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="123570" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617666" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8247787" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="2171007|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004458905" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18203166</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26552811</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe1722Valfs*5) in the FREM2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FREM2 are known to be pathogenic (PMID: 18203166, 26552811). This variant is present in population databases (rs769926034, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with FREM2-related conditions. ClinVar contains an entry for this variant (Variation ID: 983512). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FREM2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.39266642_39266643insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3097309" SubmissionDate="2021-03-31" DateLastUpdated="2021-05-05" DateCreated="2021-05-05">
        <ClinVarSubmissionID localKey="UCSF747.2|OMIM:617666" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001573078" DateUpdated="2021-05-05" DateCreated="2021-05-05" Type="SCV" Version="1" SubmitterName="Genomic Medicine Lab, University of California San Francisco" OrgID="506696" OrganizationCategory="laboratory" OrgAbbreviation="UCSF GML" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Exome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FREM2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_207361.4:c.5162dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617666" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-P3EGS</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9397059</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3097309" TraitType="Disease" MappingType="XRef" MappingValue="617666" MappingRef="OMIM">
        <MedGen CUI="C4540036" Name="Fraser syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2845700" TraitType="Disease" MappingType="XRef" MappingValue="617666" MappingRef="OMIM">
        <MedGen CUI="C4540036" Name="Fraser syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8247787" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5036921" TraitType="Disease" MappingType="XRef" MappingValue="617666" MappingRef="OMIM">
        <MedGen CUI="C4540036" Name="Fraser syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429330" TraitType="Disease" MappingType="XRef" MappingValue="617666" MappingRef="OMIM">
        <MedGen CUI="C4540036" Name="Fraser syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429330" TraitType="Disease" MappingType="XRef" MappingValue="123570" MappingRef="OMIM">
        <MedGen CUI="C1852453" Name="Isolated cryptophthalmia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

